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Intracellular trafficking of BK Virus (BKV) in human renal proximal tubular epithelial cells (HRPTEC) is critical for BKV nephritis. However,
the major trafficking components utilized by BKV remain unknown. Coincubation of HRPTEC with BKV and microtubule disrupting agents
prevented BKV infection as detected by immunofluorescence and western blot analysis with antibodies which recognize BKV large T antigen.
However, inhibition of a dynein, cellular motor protein, did not interfere with BKV infection in HRPTEC. A colocalization study of BKV with the
markers of the endoplasmic reticulum (ER) and the Golgi apparatus (GA), indicated that BKV reached the ER from 6 to 10 h, while bypassing the
GA or passing through the GA too transiently to be detected. This study contributes to the understanding of mechanisms of intracellular trafficking
used by BKV in the infection of HRPTEC.
© 2007 Elsevier Inc. All rights reserved.Keywords: BK Virus; Polyoma virus; Human renal proximal tubular epithelial cells; Microtubules; Microtubules dynamicity; Dynein; Endoplasmic reticulum; Golgi
apparatusIntroduction
To elucidate the details of pathogenesis of viral disease,
progress of viral infection, and efficient therapeutic strategy,
investigation of viral life cycle is necessary. In most types of
viruses, a specific receptor is used to attach to the cell surface
and enter into the cytoplasm via a clathrin-mediated endocytosis
pathway (Damm and Pelkmans, 2006; Marsh and Helenius,
2006; Pelkmans and Helenius, 2003). After penetration through
clathrin-coated pits, clathrin-coated vesicles move along the
microtubules, are transported to early endosomes by membrane
fusion and then delivered to the late endosomes and lysosomes.
Transportation of some viruses along the microtubules is
dependent on the activity of the microtubule motor protein
dynein. After viruses reach the nuclear membrane, the viral
genome is released into the nucleus, DNA replication occurs,
and daughter viruses are released when the cells are lysed. With
regard to polyoma viridae, JC Virus has been reported to enter⁎ Corresponding author. Fax: +1 414 456 6515.
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doi:10.1016/j.virol.2007.09.030into cells via clathrin-coated pits (Pho et al., 2000), but simian
virus 40 (SV40), mouse polyoma virus (mPy), and BK Virus
(BKV) have been reported to enter into cells via caveolae
mediated endocytosis pathway (Chen and Norkin, 1999; Eash
et al., 2004; Gilbert and Benjamin, 2000, 2004; Moriyama et al.,
2007; Nichols, 2003; Pelkmans et al., 2001; Pelkmans and
Helenius, 2002, 2003; Pelkmans, 2005; Pietiäinen et al., 2005;
Pfeffer, 2001; Richterová et al., 2001). A number of studies
have focused on the intracellular trafficking pathway of SV40,
mPy, and BKVafter caveolae endocytosis (Ashok and Atwood,
2003; Bernacchi et al., 2004; Eash and Atwood, 2005; Gilbert
and Benjamin, 2004; Gilbert et al., 2003; Norkin et al., 2002;
Norkin and Kuksin, 2005; Tagawa et al., 2005), but little is
known about the intracellular trafficking pathway of BKV after
caveolar mediated endocytosis into HRPTEC.
For SV40, virus particles were trapped in caveolae, were
coated with caveolin-1 containing membrane, surrounded by
monomeric actin, and pinched off (Chen and Norkin, 1999;
Pelkmans and Helenius, 2003; Pfeffer, 2001). Subsequently,
caveolin-1 coated SV40 particles fused with caveosomes which
were positive for caveolin-1 and did not contain any markers of
Fig. 1. Noc interfered with BKV infection. HRPTEC were pre-incubated with Noc (6.25, 12.5, 25, and 50 μM) for 1 h prior to coincubation with BKV (MOI 0.5 FFU/
cell) and Noc. After 72 h medium was removed, cells were washed three times with REBM with 0.5% FBS and incubated for another 48 h with fresh medium
containing Noc. (A) After incubation, cells were fixed and analyzed by IF (magnification ×20). T-Ag positive cells were counted as BKV infected cells and DAPI
stained nuclei were counted as total cells. Untreated HRPTEC (control) and HRPTEC incubated with only BKV (BKV) were used as negative and positive controls. At
least 500 cells were counted from each three independent cover slips and means and SE were calculated from two independent experiments. ⁎Pb0.001. (B) After
incubation, cells were harvested and analyzed by WB. Relative T-Ag expression was expressed as graph bars following measurement of band intensity by Odyssey®.
Relative intensity of T-Ag expression was normalized using the intensity of GAPDH as loading control. Means and SE were calculated from two independent
experiments. ⁎Pb0.001.
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(Bernacchi et al., 2004; Norkin et al., 2002). Transportation of
SV40 required intact functional microtubules (Zhou et al.,
1995), but it did not rely on the motor protein dynein (Ashok and
Atwood, 2003). After several hours, SV40 had reached to the
endoplasmic reticulum (ER), but bypassed the Golgi apparatus
(GA) (Bernacchi et al., 2004; Damm and Pelkmans, 2006;
Norkin and Kuksin, 2005; Pelkmans et al., 2001, 2002;
Pelkmans and Helenius, 2002; Pelkmans, 2005; Pietiäinen
et al., 2005; Radtke et al., 2006; Richards et al., 2002; Richterová
et al., 2001; Sanjuan et al., 2003; Tagawa et al., 2005).
Endocytosis of mPy was reported to depend on its cell
type. mPy entered into murine fibroblasts and primary baby
mouse kidney epithelial cells through a caveolae- and clathrin-
independent pathway (Gilbert and Benjamin, 2000; Gilbert et al.,
2003) while entering normal murine mammary gland epithelial
cells via caveolae-dependent pathway (Sanjuan et al., 2003).
Whether or not endocytosis depended on caveolae, mPy particles
were reported to be transported along microfilaments and
microtubules, and delivered to the ER, but not to the GA (Gilbert
et al., 2003; Gilbert and Benjamin, 2004; Lilley et al., 2006;
Mannová and Forstová, 2003; Sanjuan et al., 2003).
With regard to BKV, we previously reported that BKV
entered into HRPTEC through caveolae (Moriyama et al., 2007).
After internalization through caveolae, BKV particles were
fused with each other and became clusters of vesicles called
caveosome (Drachenberg et al., 2003). The BKV intracellular
trafficking pathway in Vero cells was reported to include
transportation along microtubules, but BKV movement was not
dependent upon microtubules dynamics (Dugan et al., 2006;
Eash and Atwood, 2005). BKV was also reported to be trans-
ported to the ER before reaching the nucleus, since brefeldin A,
an inhibitor of protein trafficking from the ER to the GA,
interfered with BKV infection in HRPTEC, and the ER
membrane contained receptors for BKV (Low et al., 2006).
However, it is yet to be determined whether intracellular
trafficking pathway of BKV particles in their natural target
cells, HRPTEC, requires intact and dynamic microtubules.
Additionally, it has not been determined whether dynein, a
microtubule motor protein which mediates transportation of
several types of viruses, is required for the transportation of
BKV. Although BKV is transported to the ER in HRPTEC, it is
still unclear whether BKV is transported to the GA. In this
study, we examined the intracellular trafficking pathway of
BKV using several pharmacological agents. Nocodazole (Noc)
and colcemid (Col) were used as microtubule depleting agents.
Paclitaxel (Pac) was used as a microtubule stabilizing agent (it
also depleted the dynamics of microtubules), and erythro-9-(2-
hydroxy-3-nonyl) adenine hydrochloride (EHNA) as a dynein
inhibitor. We also examined colocalization of cesium chlorideFig. 2. Col interfered with BKV infection. HRPTEC were pre-incubated with Col (0.1
cell) and Col for 72 h. Medium was removed, cells were washed three times with REB
Col. (A) After incubation, cells were fixed and analyzed by IF (magnification ×20).
calculated against DAPI stained nuclei as total cells. At least 500 cells were counted
two independent experiments. ⁎Pb0.001. (B) After incubation, cells were harvested
measurement the intensity by Odyssey®. Intensity of T-Ag expression was revised by
two independent experiments. ⁎Pb0.001. Control stands for HRPTEC neither incub(CsCl)-purified and labeled BKV with the ER and/or the GA.
Our data provide a detailed analysis of the intracellular
trafficking pathway of BKV in HRPTEC.
Results
The role of microtubules in BKV infection
BKV particles were shown to move along the microtubules
in monkey derived Vero cells (Dugan et al., 2006; Eash and
Atwood, 2005). In order to investigate the precise mechanism of
BKV uptake pathway in humans, we used microtubule dis-
rupting agents Noc and Col in HRPTEC, which are main target
of BKV infection in actual BKV clinical situation.
In control HRPTEC (untreated or incubated only with
microtubule disrupting agents), immunofluorescense (IF) anal-
ysis did not reveal any T-Ag positive cell. When HRPTEC were
incubated with BKValone, the percentage of infected cells were
36.68±1.47%. But when HRPTECwere coincubated with BKV
and several doses of Noc (6.25, 12.5, 25, and 50 μM), the
percentage of infected cells was significantly decreased in
comparison to HRPTEC incubated with BKValone (Pb0.001),
and there was a significant decreasing trend with increasing dose
of Noc (Pb0.001) (Fig. 1A). In western blot (WB) analysis,
there was no T-Ag expression in control groups (untreated
HRPTEC and HRPTEC incubated with Noc alone) as expected.
In HRPTEC, coincubated with BKV, increasing doses of Noc
decreased the relative T-Ag expression when compared to
HRPTEC incubated with BKVonly (Pb0.001) (Fig. 1B).
Fig. 2A showed that the percentage of BKV infected cells
was significantly lower when HRPTEC were coincubated with
BKV plus several doses of Col (Pb0.001) when compared to
HRPTEC incubated with BKV alone. There was also a
significant decreasing trend with increasing dose of Col
(Pb0.001). Fig. 2B shows the significant differences in relative
T-Ag expression when HRPTEC were incubated with BKV
alone compared to HRPTEC coincubated with BKVand several
doses of Col (Pb0.001). This significant trend of decreasing T-
Ag expression also continued when HRPTEC were incubated
with BKV and several doses of Col (Pb0.001).
These results indicate that BKV moves along with micro-
tubules in HRPTEC which is similar to transportation of BKV
in Vero cells.
Effect of dynamics of microtubules on BKV infection
It has been reported that transportation of BKV along
microtubules did not require dynamics of microtubules in Vero
cells (Dugan et al., 2006; Eash and Atwood, 2005). However,
since the role of microtubule dynamics for BKV transportation25, 0.25, 0.5, and 1 μM) for 1 h prior to coincubation with BKV (MOI 0.5 FFU/
M with 0.5% FBS and incubated for another 48 h with fresh medium containing
T-Ag positive cells were counted as BKV infected cells and the percentage was
from each three independent cover slips and means and SE were calculated from
and analyzed by WB. Relative T-Ag expression was detected as graph bars by
the intensity of GAPDH as loading control. Means and SE were calculated from
ated with BKV nor Col. BKV stands for HRPTEC incubated with BKV alone.
339T. Moriyama, A. Sorokin / Virology 371 (2008) 336–349in HRPTEC has not been elucidated, we investigated it potential
role in HRPTEC using treatment with Pac, which disrupted
microtubules dynamics.The percentage of BKVinfected cells detected by IF analysis,
was significantly lower when HRPTEC were coincubated with
BKV and several doses of Pac (Pb0.001), in comparison to
340 T. Moriyama, A. Sorokin / Virology 371 (2008) 336–349HRPTEC incubated with BKV alone (Fig. 3A), and there was
also a significant decreasing trend with increasing dose of Pac
(Pb0.001). In WB analysis, relative T-Ag expression was
significantly lower in HRPTEC with BKV and higher doses of
Pac (Pb0.001: 5, 10, and 20 μM), in comparison to HRPTEC
incubated with BKV alone, and there was a significant
decreasing trend with dose (Pb0.001) (Fig. 3B).
These data suggest that dynamics of microtubules plays an
important role for transportation of BKV in HRPTEC, which is
different from what was demonstrated in Vero cells.
Dynein was not required for the BKV transportation
Dynein is the motor protein on the microtubules and it plays
an important role for the transportation of the vesicles, granules,
and molecules along the microtubules in the cytoplasm. Several
viruses also have been reported to be transported by this motor
protein (Greber and Way, 2006; Leopold and Pfister, 2006;
Radtke et al., 2006). To evaluate the role of dynein, we have
used EHNA. EHNA has been known as an inhibitor of aden-
osine triphosphate (ATP)ase activity of the dynein complex
which correlates with dynein motility (Bouchard et al., 1981;
Cheung et al., 2004; Dhani et al., 2003).
Fig. 4A showed that the percentage of BKV infected cells
was not significantly different between HRPTEC incubated
with BKV alone and HRPTEC coincubated with BKV and
several doses of EHNA. Fig. 4B also showed no differences in
relative T-Ag expression between HRPTEC incubated with
BKV alone and those coincubated with BKV and EHNA.
Inhibition of the dynein motor function results in disruption of
GA which is accompanied by a dramatic distribution of GA
markers to dot-like structures (Ashok and Atwood, 2003;
Arasaki et al., 2007; Burkhardt et al., 1997; Cheung et al., 2004;
Presley et al., 1997). Fig. 4C demonstrates that EHNA was
efficient in inhibition of dynein function in HRPTEC in our
experiments as revealed by re-localization of GA marker. GA
was seen as located perinuclear cisterna in untreated HRPTEC,
whereas treatment with EHNA caused dispersal of the GA
(Fig. 4C). Therefore, as expected, EHNA was efficient in
inhibiting the motor function of dynein in HRPTEC. These
results indicate that dynein function is dispensible for BKV
infection of HRPTEC.
Colocalization of labeled and purified BKV with ER or GA
Fig. 5A shows the colocalization of Alexa Fluor™ 488
labeled and CsCl purified BKV (green) with the ER (red).
HRPTEC were incubated with BKV at MOI 5 FFU/cell from 2
to 16 h. At 2 h, a few BKV particles were located on the cellFig. 3. Pac interfered with BKV infection. HRPTEC were pre-incubated of Pac (2.5, 5
Pac for 72 h. Medium was removed, cells were washed three times with REBM wit
(A) After incubation, cells were fixed and analyzed by IF (magnification ×20). T-
calculated against DAPI stained nuclei as total cells. At least 500 cells were counted
three independent experiments. ⁎Pb0.001. (B) After incubation, cells were harveste
measurement the intensity by Odyssey®. Intensity of T-Ag expression was revised by
three independent experiments. ⁎Pb0.001. Control stands for HRPTEC neither incusurface. No colocalization of BKV particles with ER was
observed at this time. At 4 h, some BKV particles were located
on the cell surface and the others in the cytoplasm, and viral
particles started to colocalize with the ER. At 6 and 8 h, a
majority of BKV particles were located in the cytoplasm, and
several viral particles were colocalized with the ER. After 10 h
incubation, almost all BKV particles were located in the
cytoplasm, and some of them were colocalized with the ER, but
others were located in the perinuclear cisterna. Fig. 5B shows
the colocalization of labeled BKV with the GA. Throughout the
incubation period, labeled BKV were not seen adjacent to the
GA, though a lot of BKV particles were located in the
perinuclear cisterna and a few particles were located in the
nucleus after 6 h. Fig. 5C showed the colocalization rate of
BKVand the ER or the GA. Colocalization rate of BKVand the
ER was increased gradually from 2 to 6 h, peaked at 6 h
incubation (13.29±1.68%), and tapered off after 8 h incubation.
Colocalization rate of BKV with the ER at 6, 8, 10, and 12 h was
significantly higher than at 2 h (Pb0.001). Colocalization rate of
BKV with the GA also remained low all through the incubation
period, and significantly lower than colocalization rate of BKV
and the ER at 6, 8, 10, 12, and 14 h (Pb0.0001: 6 and 8 h,
Pb0.001: 10 and 12 h, and Pb0.01: 14 h). Colocalization rate of
BKV particles with caveolin-1 (major structural component of
caveolae) (Moriyama et al., 2007) is also shown to illustrate the
fact that prior to arrival at the ER, BKV particles are associated
with caveolae.
These results indicate that BKV reaches the ER mostly at 6 to
8 h after infection, but bypasses the GA or passes through the
GA at times points other than those which we studied. The
intracellular trafficking pathway of BKV is similar to those used
by other polyoma viruses, SV40 and mPy.
Discussion
A few previous studies addressed the uptake pathways
utilized by BKV in a number of mammalian cells. Previous
reports indicated that gangliosides GD1b and GT1b played a
pivotal role as a receptor of BKV in human prostate carcinoma
cells and BKV passed through the ER before reaching the
nucleus in HRPTEC (Low et al., 2006). Atwood et al. reported
that N-linked glycoprotein with α (2, 3)-linked sialic acid
served as a receptor for BKV (Dugan et al., 2005). BKV entry
involved a caveolae-mediated pathway (Eash et al., 2004), and
required microfilament dynamics and intact microtubules, but
not actin filaments and dynamic state of the microtubules
filaments in the early steps of viral infection in monkey derived
Vero cells (Eash and Atwood, 2005). We have previously
reported that BKV entered HRPTEC through caveolae, but not, 10, and 20 μM) for 1 h prior to coincubation with BKV (MOI 0.5 FFU/cell) and
h 0.5% FBS and incubated for another 48 h with fresh medium containing Pac.
Ag positive cells were counted as BKV infected cells and the percentage was
from each three independent cover slips and means and SE were calculated from
d and analyzed by WB. Relative T-Ag expression was detected as graph bars by
the intensity of GAPDH as loading control. Means and SE were calculated from
bated with BKV nor Pac. BKV stands for HRPTEC incubated with BKValone.
341T. Moriyama, A. Sorokin / Virology 371 (2008) 336–349through clathrin-coated pits, and BKV particles were routingly
trapped in caveolae at 4 h after infection (Moriyama et al.,
2007). However, the details and kinetics of the intracellular
trafficking pathway employed by BKV, following endocytosisthrough caveolae, have not been fully understood, particularly
in cells naturally targeted by BKV (HRPTEC). In this study, we
showed the time course of BKV intracellular trafficking from
microtubules to the ER (bypassing the GA) and evaluated the
342 T. Moriyama, A. Sorokin / Virology 371 (2008) 336–349role of microtubule dynamics and the motor protein dynein in
BKV infection of HRPTEC.
Initially, we focused on the role of intact microtubules and
their dynamics in BKV transportation in the cytoplasm ofHRPTEC. Microtubules are cytoskeletal filaments consisting of
α- and β-tubulin dimers, and their function is to determine
intracellular structure for the maintenance of cell shape, cell
motility, as well as intracellular transport of molecules, vesicles,
Fig. 4. EHNAwas not required for BKV infection. HRPTEC were pre-incubated EHNA (6.25, 12.5, 25, and 50 μM) for 1 h prior to coincubation with BKV (MOI
0.5 FFU/cell) and EHNA for 72 h. Mediumwas removed, cells were washed three times with REBMwith 0.5% FBS and incubated for another 48 h with fresh medium
containing EHNA. (A) After incubation, cells were fixed and analyzed by IF (magnification ×20). T-Ag positive cells were counted as BKV infected cells and the
percentage was calculated against DAPI stained nuclei as total cells. At least 500 cells were counted from each three independent cover slips and means and SE were
calculated from two independent experiments. (B) After incubation, cells were harvested and analyzed by WB. Relative T-Ag expression was expressed as graph bars
following measurement of the band intensity by Odyssey®. Relative intensity of T-Ag expression was normalized by the use of GAPDH band intensity as loading
control. Means and SE were calculated from two independent experiments. In this instance, control means HRPTEC not incubated with either BKVor EHNA. BKV
means HRPTEC incubated with BKV alone. (C) HRPTEC were incubated with or without several doses (6.25, 12.5, 25, and 50 μM) of EHNA for 5 days. After
incubation, cells were fixed, immunofluorescenced by Golgi marker Mannosidase II, and analyzed by confocal microscope with 63× objective lens. Scale bars are
10 μm.
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sists of shrinking and growing of tubulin dimers at microtubule
ends, and this is essential for the separation and movements of
chromosomes on the mitotic spindle. Interestingly, previous
reports suggested that mPy and SV40 were transported along
microtubules after caveolae endocytosis (Bernacchi et al., 2004;
Gilbert and Benjamin, 2004; Gilbert et al., 2003; Norkin et al.,
2002; Tagawa et al., 2005). BKV moved along the microtubules
in Vero cells (Eash et al., 2004), but the dynamics of
microtubules was not required for the transportation of BKV
(as well as mPy) in contrast to SV40 (Zhou et al., 1995). We
used Noc and Col as microtubule disrupting agents, and Pac as
microtubule dynamics disrupting agents. Noc disrupts micro-
tubules by binding to β-tubulin and preventing formation of one
of the two interchain disulfide linkages. Col is related to
colchicine but it is less toxic. Col depolymerizes microtubules
and limits microtubule formation. Pac has the opposite effect of
Noc and Col and binds to the N-terminal region of β-tubulin,
promoting the formation of highly stable microtubules that
resist depolymerization, and suppresses the dynamics of
microtubles. Colchicine and Pac are actually used in the treat-
ment of cancer. Our results showed all three agents interfered
with BKV infection in HRPTEC, indicating that transportation
of BKV required not only intact microtubules, but also their
dynamics. Our data suggesting the BKV requirement for intact
microtubules support previously reported data about mPy,
SV40, and BKV intracellular transportation, but with regard to
the dynamics of microtubules, our results were different from
those reported for mPy and BKV in Vero cells (Bernacchi et al.,
2004; Eash and Atwood, 2005; Gilbert and Benjamin, 2004;
Gilbert et al., 2003; Norkin et al., 2002; Tagawa et al., 2005).Eash and Atwood (2005) reported that suppression of the
microtubules dynamicity did not interfere with BKV infection
in Vero cells. These discrepancies may be explained by the fact,
that different cells were used in these studies. In a similar
manner to our results, transportation of SV40 in CV-1 cells was
reported to be inhibited by Pac, indicating that the dynamics of
microtubules was required for transportation of SV40 (Zhou
et al., 1995). Microtubule-dependent vesicle transport was also
reported to be inhibited by Pac (Hamm-Alvarez et al., 1993,
1994, 1996; Sonee et al., 1998). Observation that microtubule
dynamics was associated with transportation of molecules and
viral particles supports our conclusions.
The other factors, which play an important role in the
intracellular transportation of vesicles, granules, and molecules,
are motor proteins dynein and kinesin, which move cargo along
the microtubules. In particular, dynein is a minus-end
microtubule motor protein, binds to the microtubule organizing
center (MTOC) near the nucleus, and is known to transport a
wide variety of viruses, such as Adenovirus, African swine
fever virus, Canin Parvovirus, Foamy virus, Herpes simplex
virus, Influenza virus X-31, Lyssavirus, Human immune
deficiency virus type1, Rabies virus, and Vaccinia virus, even
though these viruses have their own receptor and endocytic
pathway (Greber and Way, 2006; Leopold and Pfister, 2006;
Radtke et al., 2006). These reports allowed us to hypothesize
that BKV transportation along microtubules was dependent
upon dynein action. Nevertheless, our results indicated that
there was no relationship between the transportation of BKV
and dynein activity. It has been reported that other polyoma
viruses (JC virus and SV40) also did not require dynein for
intracellular transportation (Ashok and Atwood, 2003). Though
Fig. 5. Colocalization of labeled BKV with ER or GA. (A, B) Colocalization of BKV with ER or GA. HRPTEC were incubated with Alexa Fluor™ 488 labeled BKV
(green) from 2 to 16 h. After incubation, cells were fixed, immunofluorescenced by ERmarker PDI (red) (A) or Golgi marker Mannosidase II (red) (B) and analyzed by
confocal microscope with 63× objective lens. Scale bars are 10 μm. Colocalized labeled BKV particles with ER or GA were expressed as yellow pixels in merged
image. (C) Time course and quantitative analysis of colocalization. Colocalization rate of labeled BKV with ER or GAwas calculated from at least 100 cells random
selected from three independent experiments and evaluated from each indication period. Colocalization threshold and viral particle threshold were determined
automatically by finding the higher intensity value for yellow pixels and green pixels. Means and SE were calculated from at three independent experiments.
⁎Pb0.0001, ⁎⁎Pb0.001, ⁎⁎⁎Pb0.01.
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345T. Moriyama, A. Sorokin / Virology 371 (2008) 336–349a lot of viruses are transported by dynein, polyoma viridae
appear to progress along microtubules independently of dynein.
Next, we examined the subsequent trafficking pathway of
BKV after transportation along the microtubules. A previous
report indicated that BKV reached the ER in HRPTEC (Low
et al., 2006), but whether BKV passed through the GA, and thetime course of intracellular trafficking pathway was not studied.
Our colocalization study of purified and labeled BKV with the
markers of ER and GA showed that BKV passed through the
ER mostly from 6 to 8 h after infection, but bypassed the GA or
passed the GA too rapidly to be detected. These results are
similar to those obtained for other polyoma virus, mPy and SV40
Fig. 5 (continued ).
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Tagawa et al., 2005), but the course of BKV infection in
HRPTEC seemed to be relatively slow. SV40 has been reported
to be colocalized with Caveolin-1 most frequently at 0.5 h and
with perinuclear region at 4 h after infection in CV-1 cells
(Pelkmans et al., 2001). mPy has been reported to be colocalized
with cav-1 at 0.5 h, actin at 0.5 to 1 h, microtubules at 2 to 4 h,
and ER at 4 h after infection in GD1a-supplemented rat glioma
cells (Gilbert and Benjamin, 2004). As for BKV, T-Ag and VP1
protein expression started between 12 and 24 h after infection
and expressed strongly at 36 h after infection. Viral DNA
replication began from 48 h after infection by Southern blotting
analysis (Low et al., 2004). In this study, it was also reported that
the titer of BKV started to increase at 2 days after BKV infection
in HRPTEC. Thus, at least 24–48 h were necessary for
expression of viral proteins and DNA in HRPTEC. These data
are in support of our conclusions about the time course of BKV
intracellular transport and localization.
Our previous data dealing with colocalization of BKV with
caveolin-1 (Moriyama et al., 2007) taken together with the
results of our current study allow us to conceive the whole viral
life cycle in HRPTEC. In summary, after attachment to the cell
surface of HRPTEC, BKV particles move along cell surface,
and are trapped in caveolae at 4 h after infection. After endo-
cyotis via caveolae, they are transported along the microtubules
if the dynamics of microtubules is intact. This process seems to
be independent of motor protein dynein activity, and BKV
reaches the ER at 6 to 8 h after infection, bypassing the GA or
passing through the GA rapidly. BKV particles then presumably
enter into the nucleus, viral replication occurs, and daughter
viruses are delivered to other cells. This process takes at least 24
to 48 h and is very similar to SV40 infection in the polyoma
viridae.
This is the first report to demonstrate the unique time course
of BKV infection and provide evidence of the mechanism of
BKV intracellular trafficking in HRPTEC, the main natural
target of BKV. Viral life cycles are quite different in each cell
type, therefore it is important to employ HRPTEC to elucidate
precise mechanisms and kinetics of BKV infection.Materials and methods
Human renal proximal tubular epithelial cells
(HRPTEC) culture
HRPTEC, purchased from Cambrex Bio Science Inc.
(Walkersville, MD), were cultured as recommended by manu-
facturer. Briefly HRPTEC were plated for culture in renal
epithelial cell basal medium (REBM™) (Cambrex Bio Science
Inc.) containing 10% fetal Bovine serum (FBS), renal epithelial
growth media (REGM™) SingleQuots (h epidermal growth
factor (hEGF), insulin, hydrocortisone, gentamicin/amphoter-
icin-B (GA)-1000, epinephrine, triiodothyronine, transferring)
(Cambrex Bio Science Inc.), and 100 units/ml penicillin-G
(Invitrogen, Carlsbad, CA) in a humidified 5% CO2 incubator at
37 °C. Passage 6 HRPTEC was used in all experiments.
Viruses (propagation, titer, purification, and labeling)
BKV was purchased from ATCC (Manassas, VA) and was
propagated as previously described (Moriyama et al., 2007).
Briefly, HRPTEC were infected with BKV for 4 weeks with
medium changed or collected every week. After 4 weeks, the
cells were harvested by scraping. All collected medium and
harvested cells were centrifuged at 10,000 rpm for 15 min.
Pellets were re-suspended in 1/10 of the supernatant, then
frozen at −80 °C and thawed at 37 °C three times. To release
virus from the nucleus and cytoplasm, the cells were sonicated.
Then deoxycholate (Sigma-Aldrich, St. Louis, MO) was added
at a final concentration of 0.25% and incubated at 37 °C for
30 min. The lysate and medium mixtures were centrifuged at
10,000 rpm for 30 min. Supernatant was saved for experimental
use.
Viral titers were calculated as fluorescence forming units
(FFU) per ml using fluorescent focus assay (FFA) as previously
described (Moriyama et al., 2007). Briefly, 70% confluent
HRPTEC in a 24-well plate were incubated with 10-fold serial
dilutions of BKV for 72 h at 37 °C. Fresh medium was then
added and cells were incubated for another 48 h. Cells were
fixed and analyzed by an immunofluorescence method. Infected
cells were counted in five random areas of each cover slip, and
means±SE were calculated from three different cover slips of
same BKV amount.
Viral purification was achieved as previously described
(Moriyama et al., 2007). Virus-containing supernatant was
gently layered at the top of 20% sucrose and centrifuged at
100,000×g, 4 °C, for 2 h in 70 Ti Rotor (Beckman, CA). Pellets
were dissolved with buffer A (1 M Tris [pH 8], 5 M NaCl, 0.1 M
CaCl2) and sonicated for 30 s three times. The sonicated
viral sample was overlaid on CsCl density gradient (1.40 and
1.20 g/ml) and ultracentrifuged at 120,000×g, overnight. The
viral fraction was extracted, diluted with buffer A, and
ultracentrifuged on CsCl gradient again. The viral fraction was
extracted and dialyzed against buffer A at 4 °C overnight. The
purified virus was labeled with Alexa Fluor™ 488 Microscale
Protein Labeling Kit (Molecular Probes, Eugene, OR) according
to the manufacturer's instructions. Briefly, 100 μl of
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10 μl of 1 M sodium bicarbonate was added. Then 33 nM Alexa
Fluor tetrafluorophenyl ester was added to the reaction tube for
15 min. After incubation, 50 μl of the conjugate reaction mixture
was layered on the resin bed in the microcentrifuge tube and
centrifuged at 16,000×g for 1 min. The efficiency of BKV
infection in HRPTEC was not significantly affected by viral
purification and labeling, though these procedures led to de-
crease of viral titers from 4.8×107 FFU/ml to 1.0×107 FFU/ml.
Antibodies and agents
To detect T-Ag, anti-SV40 T antigen (Ab-2) mouse
monoclonal antibody (PAb 416) was purchased from Calbio-
chem (San Diego, CA). These antibodies cross-react with BKV
T antigen. Protein disulfide isomerase (PDI) as ER marker,
Mannosidase II as Golgi marker, and GAPDH as loading
control were purchased from Abcam (Cambridge, MA). For
immunofluorescence (IF) and western blots (WB) analysis by
Odyssey® (LI-COR, Inc., Lincoln, NE), Alexa flour™ 488 goat
anti-mouse IgG (H+L), Alexa flour™ 680 goat anti-mouse
IgG (H+L), Alexa flour™ 680 goat anti-rabbit IgG (H+L),
4′,6-diamidino-2-phenylindole, dilactate (DAPI, dilactate)
(Molecular Probes, Eugene, OR), and IRDye™ 800 conjugated
affinity purified anti-rabbit IgG (H and L) (Rockland Immuno-
chemicals Inc., Gilbertsville, PA) were purchased. Pac, Noc,
EHNA (Sigma-Aldrich) and Col (Calbiochem) were also
purchased.
Infection and treatment
In experiments using pharmacological agents, passage 6
HRPTEC were pre-incubated with each agent at 37 °C for 1 h.
BKV was then added and coincubated another 72 h at 37 °C.
After 72 h coincubation, the cells were washed and incubated
for another 48 h with medium containing each agent. HRPTEC
not incubated with BKV and any pharmacological agents were
used as negative control. The concentration of each agent that
did not affect cell viability was determined by cytotoxic assay
(CytoTox 96® Non-Radioactive Cytotoxicity Assay, Promega,
Madison, WI) according to the manufacture's protocol and were
used for all experiments.
Western blot analysis (WB analysis)
After incubation with BKV and/or inhibitors, cell mono-
layers were washed three times with phosphate buffered saline
(PBS). Cells were scraped and harvested, and these samples
were separated by sodium dodecyl sulfate-polyacryl-amide gel
electrophoresis (SDS-PAGE) using 10% Tris–HCl gel (BIO-
RAD Laboratories, Hercules, CA). Gel-separated protein bands
were blotted onto polyvinylidene diflouride (PVDF) mem-
branes (Millipore Corporation, Bedford, MA). The membranes
were blocked in Odyssey® blocking buffer (LI-COR, Inc.) at
room temperature for 1 h. After blocking, the membranes were
incubated with primary antibody (PAb 416 and GAPDH) at
4 °C overnight with constant rotation. The membranes werethen washed four times with Tris-buffered saline containing
0.1% Tween-20 (TTBS) at room temperature for 5 min with
agitation, and incubated with secondary antibody (Alexa flour
680™ and IRDye™ 800). The membranes were washed four
times with TTBS at room temperature for 5 min with agitation.
Bands were visualized by Odyssey® infrared imaging system.
Integrated intensity of each signal was measured by
Odyssey®, and relative intensity of T-Ag revised by GAPDH
was expressed as graph bars.
Indirect immunofluorescence analysis (IF analysis)
HRPTEC seeded on cover slips were fixed in 100% meth-
anol at −20 °C for 20 min after 3 times washes with PBS. After
incubation in TTBS containing 3% bovine serum albumin
(BSA) for 30 min, cells were incubated with primary antibody
(1 μg/ml PAb 416, 1:100 dilution of PDI, or 1:200 dilution of
Mannosidase II) diluted with TTBS containing 1% BSA for 1 h,
and washed three times with TTBS for 5 min each. Cells were
then incubated with secondary antibody (1:200 dilution of
Alexa flour™ 488 or 680) for 40 min, and washed three times
with TTBS for 5 min each. To stain nuclei, cells were incubated
with DAPI (300 nM) for 5 min and washed three times with
PBS.
To determine the percentage of infected cells, a fluorescent
microscope (Nikon Eclipse E600) was used to observe cells,
and SPOT® version 4.0.9 (Diagnostic instruments, Scotland,
UK) was used to capture images. The number of T-Ag positive
cells as BKV infected cells and the number of DAPI stained
nuclei as total cell numbers were counted automatically by the
MetaVue™ Imaging System (Sunnyvale, CA), and the per-
centage of infected cells was calculated by using formula shown
below.
Percentage of infected cells
¼ number of T−Ag positive cells
= number of DAPI stained nuclei 100:
To investigate the colocalization of labeled BKV with ER or
GA, HRPTEC were incubated with labeled BKVat MOI 5 FFU/
cell from 2 to 16 h at 37 °C. A confocal microscope (Leica TCS
SP5) was used to observe cells and Leica application suite
advanced fluorescence was used to capture images. Colocaliza-
tion area and viral particles area were recognized by the
MetaVue™ Imaging System and colocalization rate was
calculated by using formula shown below.
Colocalization rate
¼ Area of viral particles colocalized with ER or GA
=Area of total viral particles  100:
Statistical analysis
All experiments were repeated at least twice. Means±SE
was calculated from repeated data. A factorial analysis of
variance was used to compare western blot analysis and the
percentage of infected cells. Linear contrasts were used to test
348 T. Moriyama, A. Sorokin / Virology 371 (2008) 336–349for trend and multiple comparisons used the sidak method for
adjustment. The comparison of the colocalization rate over time
used a two-factor repeated measures ANOVA.
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